Interstitial lung diseases (ILDs) refer to a heterogeneous and complex group of conditions
characterized by inflammation, fibrosis, or both, in the interstitium of the lungs. This results in …

Progressive fibrotic interstitial lung diseases (ILDs) are characterised by major reductions in
quality of life and survival and have similarities to certain malignancies. However, palliative …

Telomere biology disorders (TBD) are a heterogeneous group of diseases arising from
germline mutations affecting genes involved in telomere maintenance. Telomeres are DNA …

Background People with pulmonary fibrosis often experience a protracted time to diagnosis,
high symptom burden and limited disease information. This review aimed to identify the …

Rationale: Cough is a key symptom in patients with fibrotic interstitial lung disease (ILD).
Objectives: This study evaluated the prevalence, longitudinal change, associations, and …

Background: Research has extensively examined family members' grief prior to the death of
an individual with a life-limiting illness but several inconsistencies in its conceptualization of …

Introduction Pulmonary fibrosis (PF) and its most common form, idiopathic pulmonary
fibrosis (IPF), are chronic, progressive diseases resulting in increasing loss of lung function …

Pulmonary Fibrosis (PF) describes a group of lung diseases characterised by progressive
scarring (fibrosis). Symptoms worsen over time and include breathlessness, tiredness, and …

Rationale Chronic cough is a common symptom in patients with interstitial lung disease
(ILD), negatively contributing to health-related quality of life. Despite this, there is limited …

Aims Patients diagnosed with idiopathic pulmonary fibrosis (IPF) have a high symptom
burden and numerous needs that remain largely unaddressed despite advances in …